Posted by Michael Wonder on 05 Jun 2023
New treatments for Australians with endometrial cancer and Lennox-Gastaut syndrome
5 June 2023 - From 1 June 2023, Australians with endometrial cancer and Lennox-Gastaut syndrome will have access to new treatment options through the PBS.
Pembrolizumab (Keytruda) and lenvatinib (Lenvima) will be expanded for use in combination to treat patients with advanced endometrial cancer whose disease continues to progress after prior therapy.
